{"id":46574,"date":"2026-04-09T16:15:06","date_gmt":"2026-04-09T16:15:06","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/46574\/"},"modified":"2026-04-09T16:15:06","modified_gmt":"2026-04-09T16:15:06","slug":"novartis-loses-appeal-to-halt-mississippi-drug-discount-law","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/46574\/","title":{"rendered":"Novartis Loses Appeal to Halt Mississippi Drug Discount Law"},"content":{"rendered":"<p>Novartis AG failed to convince a federal appeals court that a Mississippi law requiring drug manufacturers to distribute discounted medicines to an unlimited number pharmacies should be blocked.<\/p>\n<p>The US Court of Appeals for the Fifth Circuit on Thursday <a href=\"https:\/\/www.bloomberglaw.com\/product\/blaw\/document\/XNN252JB099TB0IOGF7EHJB4M\" rel=\"nofollow noopener\" target=\"_blank\">upheld<\/a> a lower court order that <a data-terminal-id=\"SG0761DWX2PS\" href=\"https:\/\/news.bloomberglaw.com\/health-law-and-business\/novartis-phrma-lose-bid-to-block-mississippi-drug-pharmacy-law\" rel=\"nofollow noopener\" target=\"_blank\">rejected<\/a> Novartis\u2019s bid for a preliminary injunction to halt Mississippi\u2019s <a href=\"https:\/\/billstatus.ls.state.ms.us\/documents\/2024\/html\/HB\/0700-0799\/HB0728IN.htm\" rel=\"nofollow noopener\" target=\"_blank\">H.B.728<\/a>, a law now in effect that prohibits any effort from drugmakers to deny, restrict, or prohibit drug discounts to pharmacies that contract with providers in the federal 340B Drug Pricing Program.<\/p>\n<p>The company argued the state law is preempted by federal law and &#8230;<\/p>\n","protected":false},"excerpt":{"rendered":"Novartis AG failed to convince a federal appeals court that a Mississippi law requiring drug manufacturers to distribute&hellip;\n","protected":false},"author":2,"featured_media":46575,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[127],"tags":[14505,19367,206,26977,26979,26978],"class_list":{"0":"post-46574","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-novartis","8":"tag-drug-pricing","9":"tag-hospitals","10":"tag-novartis","11":"tag-pharmacy-care","12":"tag-preemption","13":"tag-uninsured-patients"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116375645436556276","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/46574","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=46574"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/46574\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/46575"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=46574"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=46574"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=46574"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}